30

Jiangsu Hualan New Pharmaceutical Material Co LtdSHE 301093 Stock Report

Last reporting period 30 Sep, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

1.001

Small

Exchange

XSHE - Shenzhen Stock Exchange

301093.SZ Stock Analysis

30

Uncovered

Jiangsu Hualan New Pharmaceutical Material Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

80/100

Moderate score

Market cap $B

1.001

Dividend yield

4.50 %

Shares outstanding

134.67 B

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. engages in the manufacture and production of direct or indirect pharmaceuticals contact injection drugs. The company is headquartered in Wuxi, Jiangsu and currently employs 861 full-time employees. The company went IPO on 2021-11-01. The Company’s main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The firm's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The firm also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The firm distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.

View Section: Eyestock Rating